Research Library › Analytical and functional evidence
Peptide purity vs potency is a distinction between analytical composition and measured biological activity. A chromatographic purity result can be useful without answering whether a material produces a particular response in an experimental system.
What does each term describe?
- Chromatographic purity: the reported distribution of detector response under a stated separation and integration method.
- Identity: evidence supporting which material was tested.
- Quantitative content: the amount or mass fraction defined by a quantitative measurement.
- Biological potency: a quantitative assessment of biological activity in a specified measurement framework.
ICH Q6B distinguishes biological activity and potency within its discussion of biological products [1]. That pharmaceutical guideline is used here for terminology and measurement context, not to claim approval, pharmaceutical status, or guideline compliance for Not Labs research materials.
Does a high purity result prove biological activity?
No. A purity result and a functional result address different attributes. A certificate reporting chromatographic purity should not silently be relabeled as a receptor-activity test, a cell-response assay, or evidence of potency.
The same distinction applies to mass-based identity evidence. Identifying the intended material is important, but an identity result alone does not demonstrate a particular biological response. Review Purity vs Identity and Peptide Content vs Purity for those separate analytical questions.
What context does a functional result need?
A functional result should remain attached to its assay. Record the tested material and lot, model, endpoint, control groups, reference material, reporting units, and analysis method. If a relative result is reported, identify what it is relative to.
NIST’s bioassay work emphasizes measurement and calibration considerations [2]. Its publication on positive-control selection discusses characteristics such as mechanism, stability, response range, and interference [3]. These are useful reminders that a working assay needs more than an active-looking signal.
A response in one cellular system may not establish the same response in another system. Compare matched conditions before treating separate results as a ranking of materials.
Three documentation scenarios
- Purity reported; activity not reported. Record the purity result with its method and leave biological activity as a separate, unanswered question.
- Activity reported without clear assay context. Ask which endpoint, control, reference material, and units support the result.
- Analytical and functional results both reported. Review each on its own terms, then check that both connect to the material being evaluated.
These scenarios describe report review, not a pass/fail specification. A research protocol should define which attributes and supporting evidence are required for its application.
Can a literature paper verify a current batch’s potency?
A paper can provide research context for a compound. It does not automatically verify a current supplier lot. The material used in the paper, its preparation, the experimental system, and the tested endpoint may differ from the material and application being considered.
Keep compound-level literature and lot-level records separate. If the protocol requires functional qualification, identify the evidence needed instead of inferring it from a publication, product name, purity percentage, or nominal vial quantity.
A practical review before selection
Use How to Read a Peptide COA to record what the certificate actually reports. Use the batch-comparison worksheet to align units, methods, and lot records. Visit Testing & Verification and the current research-compound listings for the documentation supplied for a material.
Technical references
- ICH Q6B specifications guideline. Terminology and methodological background for biological activity and potency.
- NIST. Statistical Support for Bioassay Standard Development.
- NIST publication record (2021). Characteristics to Consider when Selecting a Positive Control Material for an In Vitro Assay.